Respiratory Diagnostics Market Size, Trends, Analysis, and Outlook By Products and Services (Instruments & Devices, Assays & Reagents, Services & Software), By Test (Mechanical Tests, Osa Diagnostic Tests, Imaging Tests, Traditional Diagnostic Tests, Mole

Respiratory Diagnostics Market Size, Trends, Analysis, and Outlook By Products and Services (Instruments & Devices, Assays & Reagents, Services & Software), By Test (Mechanical Tests, Osa Diagnostic Tests, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests), By Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others), By End-User (Hospitals and Clinics, Diagnostics Laboratories, Others), by Country, Segment, and Companies, 2024-2032


The global Respiratory Diagnostics market size is poised to register 7.6% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Respiratory Diagnostics market across By Products and Services (Instruments & Devices, Assays & Reagents, Services & Software), By Test (Mechanical Tests, Osa Diagnostic Tests, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests), By Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others), By End-User (Hospitals and Clinics, Diagnostics Laboratories, Others)

The Respiratory Diagnostics market is witnessing significant growth driven by the increasing demand for accurate and timely diagnosis of respiratory infections, lung diseases, and respiratory allergies. Respiratory diagnostics play a crucial role in identifying pathogens, assessing lung function, and guiding treatment decisions for patients with respiratory conditions. With the growing prevalence of respiratory diseases and the need for rapid diagnostic testing in clinical settings, there is a rising need for respiratory diagnostic tests that offer high sensitivity, specificity, and speed. Further, advancements in molecular diagnostics, point-of-care testing, and multiplexing technologies are driving market growth by enabling more comprehensive and efficient respiratory diagnostic workflows. By 2030, the market is expected to witness substantial expansion, fueled by the increasing adoption of respiratory diagnostic tests in hospitals, clinics, and emergency departments.

Respiratory Diagnostics Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Respiratory Diagnostics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Respiratory Diagnostics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Respiratory Diagnostics industry.

Key market trends defining the global Respiratory Diagnostics demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Respiratory Diagnostics Market Segmentation- Industry Share, Market Size, and Outlook to 2032

The Respiratory Diagnostics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Respiratory Diagnostics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Respiratory Diagnostics industry

Leading Respiratory Diagnostics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Respiratory Diagnostics companies.

Respiratory Diagnostics Market Study- Strategic Analysis Review

The Respiratory Diagnostics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
  • Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
  • Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
  • Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
  • Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
Respiratory Diagnostics Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Respiratory Diagnostics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.

Respiratory Diagnostics Country Analysis and Revenue Outlook to 2032

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.

North America Respiratory Diagnostics Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Respiratory Diagnostics market segments. Similarly, Strong market demand is encouraging Canadian Respiratory Diagnostics companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Respiratory Diagnostics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Respiratory Diagnostics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Respiratory Diagnostics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Respiratory Diagnostics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Respiratory Diagnostics Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Respiratory Diagnostics in Asia Pacific. In particular, China, India, and South East Asian Respiratory Diagnostics markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.

Latin America Respiratory Diagnostics Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Respiratory Diagnostics Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Respiratory Diagnostics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Respiratory Diagnostics.

Respiratory Diagnostics Market Company Profiles

The global Respiratory Diagnostics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, BIRD Healthcare, Briota Technologies Private Ltd, Compumedics Ltd, GE Healthcare, Hologic Inc, Koninklijke Philips N.V., Löwenstein Medical Technology, ndd Medizintechnik AG, Nihon Kohden Corp, ProAxsis Ltd, QIAGEN N.V., ResMed Inc, Revvity Inc, SDI Diagnostics Inc, Seegene Inc, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc, VisBy Medical Inc, Vitalograph Ltd, Vyaire Medical Inc.

Recent Respiratory Diagnostics Market Developments

The global Respiratory Diagnostics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Respiratory Diagnostics Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • SWOT Profile
  • Market Dynamics- Trends, Drivers, Challenges
  • Porter’s Five Forces Analysis
  • Macroeconomic Impact Analysis
  • Case Scenarios- Low, Base, High
Market Segmentation:

By Products and Services

Instruments & Devices

Assays & Reagents

Services & Software

By Test

Mechanical Tests

-Pulmonary Function Tests

-Spirometry

-Peak Flow Test

Osa Diagnostic Tests

Imaging Tests

-X-Ray

-Computed Tomography

-Magnetic Resonance Imaging (MRI)

-Positron Emission Tomography (PET)

-Others

Traditional Diagnostic Tests

-Immunodiagnostics

-Biochemical Tests

-Microscopy

Molecular Diagnostic Tests

-PCR

-Nucleic Acid Amplification Test

-In Situ Hybridization

-DNA Sequencing & Next-Generation Sequencing (NGS)

-Microarrays

-Others

By Indication

Tuberculosis

Asthma

Lung Cancer

Chronic Obstructive Pulmonary Disease

Others

By End-User

Hospitals and Clinics

Diagnostics Laboratories

Others

Geographical Segmentation:
  • North America (3 markets)
  • Europe (6 markets)
  • Asia Pacific (6 markets)
  • Latin America (3 markets)
  • Middle East Africa (5 markets)
Companies

Abbott Laboratories

Becton, Dickinson and Company

bioMérieux SA

Bio-Rad Laboratories Inc

BIRD Healthcare

Briota Technologies Private Ltd

Compumedics Ltd

GE Healthcare

Hologic Inc

Koninklijke Philips N.V.

Löwenstein Medical Technology

ndd Medizintechnik AG

Nihon Kohden Corp

ProAxsis Ltd

QIAGEN N.V.

ResMed Inc

Revvity Inc

SDI Diagnostics Inc

Seegene Inc

Siemens Healthcare GmbH

Thermo Fisher Scientific Inc

VisBy Medical Inc

Vitalograph Ltd

Vyaire Medical Inc

Formats Available: Excel, PDF, and PPT


1. Executive Summary
1.1 Respiratory Diagnostics Market Overview and Key Findings, 2024
1.2 Respiratory Diagnostics Market Size and Growth Outlook, 2021- 2030
1.3 Respiratory Diagnostics Market Growth Opportunities to 2030
1.4 Key Respiratory Diagnostics Market Trends and Challenges
1.4.1 Respiratory Diagnostics Market Drivers and Trends
1.4.2 Respiratory Diagnostics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Respiratory Diagnostics Companies
2. Respiratory Diagnostics Market Size Outlook to 2030
2.1 Respiratory Diagnostics Market Size Outlook, USD Million, 2021- 2030
2.2 Respiratory Diagnostics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. Respiratory Diagnostics Market- Strategic Analysis Review
3.1 Porter's Five Forces Analysis
Threat of New Entrants
Threat of Substitutes
Intensity of Competitive Rivalry
Bargaining Power of Buyers
Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. Respiratory Diagnostics Market Segmentation Analysis and Outlook
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Products and Services
Instruments & Devices
Assays & Reagents
Services & Software
By Test
Mechanical Tests
-Pulmonary Function Tests
-Spirometry
-Peak Flow Test
Osa Diagnostic Tests
Imaging Tests
-X-Ray
-Computed Tomography
-Magnetic Resonance Imaging (MRI)
-Positron Emission Tomography (PET)
-Others
Traditional Diagnostic Tests
-Immunodiagnostics
-Biochemical Tests
-Microscopy
Molecular Diagnostic Tests
-PCR
-Nucleic Acid Amplification Test
-In Situ Hybridization
-DNA Sequencing & Next-Generation Sequencing (NGS)
-Microarrays
-Others
By Indication
Tuberculosis
Asthma
Lung Cancer
Chronic Obstructive Pulmonary Disease
Others
By End-User
Hospitals and Clinics
Diagnostics Laboratories
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. Region-wise Market Outlook to 2030
5.1 Key Findings for Asia Pacific Respiratory Diagnostics Market, 2025
5.2 Asia Pacific Respiratory Diagnostics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Respiratory Diagnostics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Respiratory Diagnostics Market, 2025
5.5 Europe Respiratory Diagnostics Market Size Outlook by Type, 2021- 2030
5.6 Europe Respiratory Diagnostics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Respiratory Diagnostics Market, 2025
5.8 North America Respiratory Diagnostics Market Size Outlook by Type, 2021- 2030
5.9 North America Respiratory Diagnostics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Respiratory Diagnostics Market, 2025
5.11 South America Pacific Respiratory Diagnostics Market Size Outlook by Type, 2021- 2030
5.12 South America Respiratory Diagnostics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Respiratory Diagnostics Market, 2025
5.14 Middle East Africa Respiratory Diagnostics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Respiratory Diagnostics Market Size Outlook by Application, 2021- 2030
6. Country-wise Market Size Outlook to 2030
6.1 US Respiratory Diagnostics Market Size Outlook and Revenue Growth Forecasts
6.2 US Respiratory Diagnostics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Respiratory Diagnostics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Respiratory Diagnostics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Respiratory Diagnostics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Respiratory Diagnostics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Respiratory Diagnostics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Respiratory Diagnostics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Respiratory Diagnostics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Respiratory Diagnostics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Respiratory Diagnostics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Respiratory Diagnostics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Respiratory Diagnostics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Respiratory Diagnostics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Respiratory Diagnostics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Respiratory Diagnostics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Respiratory Diagnostics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Respiratory Diagnostics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Respiratory Diagnostics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Respiratory Diagnostics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Respiratory Diagnostics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Respiratory Diagnostics Industry Drivers and Opportunities
7. Respiratory Diagnostics Market Outlook across Scenarios
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. Respiratory Diagnostics Company Profiles
8.1 Profiles of Leading Respiratory Diagnostics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott Laboratories
Becton, Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories Inc
BIRD Healthcare
Briota Technologies Private Ltd
Compumedics Ltd
GE Healthcare
Hologic Inc
Koninklijke Philips N.V.
Löwenstein Medical Technology
ndd Medizintechnik AG
Nihon Kohden Corp
ProAxsis Ltd
QIAGEN N.V.
ResMed Inc
Revvity Inc
SDI Diagnostics Inc
Seegene Inc
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc
VisBy Medical Inc
Vitalograph Ltd
Vyaire Medical Inc.
9. Appendix
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings